Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Shapera

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Annals of the American Thoracic Society|January 25, 2021
Treatment Initiation in Patients with Interstitial Lung Disease in CanadaDeborah Assayag, Kristopher Garlick, Kerri A Johannson, et al.
Annals of the American Thoracic Society|May 22, 2020
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.
Chest|May 4, 2019
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.
Canadian Respiratory Journal|July 23, 2016
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis RegistryChristopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Canadian Respiratory Journal|November 3, 2015
The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registryChristopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Annals of the American Thoracic Society|January 25, 2021
Treatment Initiation in Patients with Interstitial Lung Disease in CanadaDeborah Assayag, Kristopher Garlick, Kerri A Johannson, et al.
Annals of the American Thoracic Society|May 22, 2020
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.
Chest|May 4, 2019
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung DiseaseMohmmed Algamdi, Mohsen Sadatsafavi, Jolene H Fisher, et al.
Canadian Respiratory Journal|July 23, 2016
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis RegistryChristopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Canadian Respiratory Journal|November 3, 2015
The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registryChristopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Chest|November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung DiseaseAlessia Comes, Alyson W Wong, Jolene H Fisher, et al.
Pageof 7